Houte Hans Van serves as Executive at Nurix Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Houte Hans Van has executed 60 insider transactions totaling $3.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 24, 2021 involved exercising options for 1,829 shares valued at $13.3K.
Houte Hans Van currently holds 37,592 shares of Nurix Therapeutics, Inc. (NRIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Houte Hans Van has been a net seller of NRIX stock. They have purchased $0 and sold $3.7M worth of shares.
Houte Hans Van's most recent insider trade was on Feb 24, 2021, when they sold 1,829 shares at $7.26 per share.
Get notified when new Form 4 filings are submitted
| 1,417 |
| $0.84 |
| Discretionary |
| Feb 22, 2021 | NRIX | $212.8K | Sale | 5,330 | $39.93 | Discretionary |
| Feb 22, 2021 | NRIX | $4.7K | Option Exercise | 3,913 | $1.20 | Discretionary |
| Feb 18, 2021 | NRIX | $107.5K | Sale | 3,140 | $34.24 | Discretionary |
| Feb 18, 2021 | NRIX | $11.4K | Option Exercise | 13,583 | $0.84 | Discretionary |
| Feb 18, 2021 | NRIX | $15.2K | Sale | 400 | $38.05 | Discretionary |
| Feb 18, 2021 | NRIX | $24.6K | Sale | 666 | $36.91 | Discretionary |
| Feb 18, 2021 | NRIX | $206.1K | Sale | 5,725 | $36.00 | Discretionary |
| Feb 18, 2021 | NRIX | $128.2K | Sale | 3,652 | $35.10 | Discretionary |